SPELTREO Trademark

Trademark Overview

On Friday, March 21, 2014, a trademark application was filed for SPELTREO with the United States Patent and Trademark Office. The USPTO has given the SPELTREO trademark a serial number of 79149147. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 17, 2021. This trademark is owned by NOVARTIS AG. The SPELTREO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for treatment of inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and for gastroenterological disorders; pharmaceutical products for the treatment of ocular disorders or diseases, for the treatment of bacterial diseases, and for the treatment of diabetes; anti-infective products, antiviral products, antibiotics, anti-fungal products
speltreo

General Information

Serial Number79149147
Word MarkSPELTREO
Filing DateFriday, March 21, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 17, 2021
Registration Number4693874
Registration DateTuesday, March 3, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for treatment of inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and for gastroenterological disorders; pharmaceutical products for the treatment of ocular disorders or diseases, for the treatment of bacterial diseases, and for the treatment of diabetes; anti-infective products, antiviral products, antibiotics, anti-fungal products

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH-4002 Basel
CH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH-4002 Basel
CH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH-4002 Basel
CH

Trademark Events

Event DateEvent Description
Sunday, September 4, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, August 8, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, August 8, 2022INVALIDATION PROCESSED
Tuesday, May 17, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 17, 2021CANCELLED SECTION 71
Tuesday, March 3, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 31, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 26, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 26, 2015FINAL DISPOSITION PROCESSED
Wednesday, June 3, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 3, 2015REGISTERED-PRINCIPAL REGISTER
Friday, December 19, 2014NOTIFICATION PROCESSED BY IB
Tuesday, December 16, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 16, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 3, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 12, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 12, 2014ASSIGNED TO LIE
Monday, October 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 23, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 23, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 20, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 20, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 17, 2014REFUSAL PROCESSED BY IB
Tuesday, September 30, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 30, 2014REFUSAL PROCESSED BY MPU
Tuesday, September 30, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 30, 2014APPLICATION FILING RECEIPT MAILED
Monday, September 29, 2014NON-FINAL ACTION WRITTEN
Monday, September 29, 2014NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, September 27, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 26, 2014NON-FINAL ACTION WRITTEN
Wednesday, September 24, 2014ASSIGNED TO EXAMINER
Wednesday, September 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 19, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, July 19, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

speltreo system treatment disorders products diseases pharmaceutical anti gastroenterological ophthalmology fungal